{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:35:27Z","timestamp":1789392927787,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejim.2010.07.014","type":"journal-article","created":{"date-parts":[[2010,8,16]],"date-time":"2010-08-16T08:10:16Z","timestamp":1281946216000},"page":"516-523","source":"Crossref","is-referenced-by-count":48,"title":["Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards"],"prefix":"10.1016","volume":"21","author":[{"given":"M.","family":"Marcucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tettamanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marengoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2010.07.014_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.155.5.469","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2010.07.014_bb0015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2009.05.058","article-title":"Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study)","volume":"104","author":"Bilato","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2010.07.014_bb0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.147.9.1561","article-title":"Atrial fibrillation: a major contributor to stroke in the elderly","volume":"147","author":"Wolf","year":"1987","journal-title":"The Framingham Study. Arch. Intern. Med."},{"key":"10.1016\/j.ejim.2010.07.014_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2105\/AJPH.88.3.395","article-title":"Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries","volume":"88","author":"Yuan","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ejim.2010.07.014_bb0030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.154.13.1449","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0045","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2010.07.014_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1445-5994.2001.00071.x","article-title":"Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice","volume":"31","author":"Jackson","year":"2001","journal-title":"Intern Med J"},{"key":"10.1016\/j.ejim.2010.07.014_bb0055","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.clinthera.2004.09.002","article-title":"Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic","volume":"26","author":"Abdelhafiz","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.ejim.2010.07.014_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<192::AID-AJH5>3.0.CO;2-K","article-title":"Bleeding risk factors in chronic oral anticoagulation with acenocoumarol","volume":"63","author":"Casais","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2010.07.014_bb0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0075","first-page":"423","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)","volume":"348","author":"Palareti","year":"1996","journal-title":"Italian Study on Complications of Oral Anticoagulant Therapy. Lancet"},{"key":"10.1016\/j.ejim.2010.07.014_bb0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.156.11.1197","article-title":"Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics","volume":"156","author":"White","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002512-199914040-00005","article-title":"Safety of treatment with oral anticoagulants in the elderly. A systematic review","volume":"14","author":"Hutten","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejim.2010.07.014_bb0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0037-1615599","article-title":"Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.","volume":"85","author":"Pengo","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2010.07.014_bb0095","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/STROKEAHA.108.537696","article-title":"Combined aspirin plus warfarin: recent evidence and residual questions","volume":"40","author":"Donnan","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.28.5.1015","article-title":"Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators","volume":"28","author":"Morocutti","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2010.07.014_bb0115","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0120","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2010.07.014_bb0125","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2010.07.014_bb0130","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics\u20132010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2010.07.014_bb0135","first-page":"493","article-title":"Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice","volume":"161","author":"Caro","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2010.07.014_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0145","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/archinte.156.20.2311","article-title":"Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals","volume":"156","author":"Albers","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0150","first-page":"695","article-title":"Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators","volume":"14","year":"1998","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejim.2010.07.014_bb0155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-131-12-199912210-00004","article-title":"Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"131","author":"Go","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0160","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/archinte.159.14.1574","article-title":"Temporal trends in the use of anticoagulants among older adults with atrial fibrillation","volume":"159","author":"Smith","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0165","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","article-title":"Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation","volume":"31","author":"Gage","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0170","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.161.20.2458","article-title":"Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting","volume":"161","author":"McCormick","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0175","first-page":"S297","article-title":"Effective anticoagulation therapy: defining the gap between clinical studies and clinical practice","volume":"10","author":"Wittkowsky","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejim.2010.07.014_bb0180","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2010.07.014_bb0185","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.STR.0000209239.71702.ce","article-title":"Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation","volume":"37","author":"Hylek","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ejim.2010.07.014_bb0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1345\/aph.1K498","article-title":"Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls","volume":"42","author":"Garwood","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2010.07.014_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1015223024268","article-title":"Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: a prospective, observational study","volume":"12","author":"Ageno","year":"2001","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejim.2010.07.014_bb0200","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehl208","article-title":"Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation","volume":"27","author":"Monte","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2010.07.014_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11739-007-0005-2","article-title":"Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy","volume":"2","author":"Ferro","year":"2007","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2010.07.014_bb0210","doi-asserted-by":"crossref","DOI":"10.1160\/TH09-08-0525","article-title":"A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care","volume":"103","author":"Mazzaglia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2010.07.014_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2010.07.014_bb0220","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1182\/blood-2007-11-123711","article-title":"Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based","volume":"111","author":"Levi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2010.07.014_bb0225","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2010.07.014_bb0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0029-1241048","article-title":"Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms","volume":"35","author":"Pisters","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2010.07.014_bb0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1497.2001.10432.x","article-title":"Is warfarin really underused in patients with atrial fibrillation?","volume":"16","author":"Weisbord","year":"2001","journal-title":"J Gen Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:35:16Z","timestamp":1559432116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620510001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0953620510001548"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2010.07.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}